Aurinia Pharmaceuticals Inc.
AUPH
$15.99
$0.271.72%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.77% | 4.96% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.77% | 4.96% | |||
| Cost of Revenue | -65.54% | 376.82% | |||
| Gross Profit | 74.29% | -43.71% | |||
| SG&A Expenses | -24.70% | 11.74% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 101.89% | -1,690.31% | |||
| Total Operating Expenses | 6.17% | -21.84% | |||
| Operating Income | -3.53% | 44.36% | |||
| Income Before Tax | 23.07% | 11.66% | |||
| Income Tax Expenses | 105.47% | -42,704.38% | |||
| Earnings from Continuing Operations | -83.70% | 568.11% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -83.70% | 568.11% | |||
| EBIT | -3.53% | 44.36% | |||
| EBITDA | -3.27% | 38.12% | |||
| EPS Basic | -83.76% | 567.34% | |||
| Normalized Basic EPS | 22.65% | 11.54% | |||
| EPS Diluted | -83.61% | 563.00% | |||
| Normalized Diluted EPS | 23.53% | 9.94% | |||
| Average Basic Shares Outstanding | 0.33% | 0.10% | |||
| Average Diluted Shares Outstanding | -0.38% | 1.58% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||